HOME › DRUGS › EMAPALUMAB
ACTIVE SUBSTANCE / INN

EMAPALUMAB

Brand name(s): Gamifant
EMA LISTED
REFUSED
Immune System Diseases
ACTIVE SUBSTANCE
Emapalumab
REGULATORS
EMA
SPONSORS / MAH
Swedish Orphan Biovitrum AB (publ)
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GamifantSwedish Orphan Biovitrum AB (publ)RefusedImmune System Diseases

FULL INTELLIGENCE ON EMAPALUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →